Metabolic syndrome: updates on pathophysiology and management in 2021

G Fahed, L Aoun, M Bou Zerdan, S Allam… - International journal of …, 2022 - mdpi.com
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …

[HTML][HTML] Targeting gut microbiota and metabolism as the major probiotic mechanism-An evidence-based review

T Ma, X Shen, X Shi, HA Sakandar, K Quan, Y Li… - Trends in Food Science …, 2023 - Elsevier
Background The human gut hosts complex microbial communities, which are linked to
health and disease. The gut microbiota is continuously reshaped by multiple environmental …

Butyrate in energy metabolism: there is still more to learn

L Zhang, C Liu, Q Jiang, Y Yin - Trends in Endocrinology & Metabolism, 2021 - cell.com
Butyrate, a main product of gut microbial fermentation, has been recognized as an important
mediator of gut microbiota regulation in whole body energy homeostasis. However, the …

[HTML][HTML] Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans

M Müller, MAG Hernández, GH Goossens… - Scientific Reports, 2019 - nature.com
Microbial-derived short-chain fatty acids (SCFA) acetate, propionate and butyrate may
provide a link between gut microbiota and whole-body insulin sensitivity (IS). In this cross …

The effect of antibiotics on the composition of the intestinal microbiota-a systematic review

P Zimmermann, N Curtis - Journal of Infection, 2019 - Elsevier
Objective Antibiotics change the composition of the intestinal microbiota. The magnitude of
the effect of antibiotics on the microbiota and whether the effects are short-term or persist …

Fatty acids, epigenetic mechanisms and chronic diseases: a systematic review

K González-Becerra, O Ramos-López… - Lipids in health and …, 2019 - Springer
Background Chronic illnesses like obesity, type 2 diabetes (T2D) and cardiovascular
diseases, are worldwide major causes of morbidity and mortality. These pathological …

Evidence for the gut microbiota short‐chain fatty acids as key pathophysiological molecules improving diabetes

A Puddu, R Sanguineti, F Montecucco… - Mediators of …, 2014 - Wiley Online Library
In type 2 diabetes, hyperglycemia, insulin resistance, increased inflammation, and oxidative
stress were shown to be associated with the progressive deterioration of beta‐cell function …

Gut microbiota, diet, and obesity‐related disorders—The good, the bad, and the future challenges

KJ Portune, A Benítez‐Páez… - Molecular nutrition & …, 2017 - Wiley Online Library
Diet has been shown to be a major factor in modulating the structure of the mammalian gut
microbiota by providing specific nutrient sources and inducing environmental changes (pH …

Short-chain fatty acid: An updated review on signaling, metabolism, and therapeutic effects

K Rekha, B Venkidasamy, R Samynathan… - Critical Reviews in …, 2024 - Taylor & Francis
Fatty acids are good energy sources (9 kcal per gram) that aerobic tissues can use except
for the brain (glucose is an alternative source). Apart from the energy source, fatty acids are …

Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome

SC Bridgeman, W Northrop, PE Melton… - Pharmacological …, 2020 - Elsevier
Metabolic syndrome (MetS) and the associated incidence of cardiovascular disease and
type 2 diabetes represents a significant contributor to morbidity and mortality worldwide …